Clinical and evolutionary characteristics of 134 patients with disseminated histoplasmosis associated with AIDS in the state of Ceará;Características clínico-evolutivas de 134 pacientes com histoplasmose disseminada associada a SIDA no estado do Ceará

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 43, Issue 1, 2010, Pages 27-31

  Pontes, Lícia Borges ^a   Leitão, Terezinha do Menino Jesus Silva ^b   Lima, Gabrielle Gurgel ^a   Gerhard, Emília Santiago ^a   Fernandes, Thyago Araújo ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

AIDS; Cear ; Disseminated histoplasmosis; Opportunistic disease

Indexed keywords

CREATININE; HEMOGLOBIN; UREA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE KIDNEY FAILURE; ARTICLE; CLINICAL FEATURE; COUGHING; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISSEMINATED HISTOPLASMOSIS; DYSPNEA; FEVER; HEMOGLOBIN BLOOD LEVEL; HEPATOMEGALY; HISTOPLASMOSIS; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; LABORATORY TEST; MAJOR CLINICAL STUDY; MEDICAL RECORD; MIXED INFECTION; RESPIRATORY FAILURE; RISK FACTOR; SPLENOMEGALY; SURVIVAL; UREA BLOOD LEVEL; VOMITING; WEIGHT REDUCTION;

EID: 77950951302     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0037-86822010000100007     Document Type: Article

References (16)

1. Gutierrez ME, Canton A, Sosa N, Puga E, Talavera L. Disseminated histoplasmosis in patients with AIDS in Panama: a review of 104 cases. Clin Infect Dis 2005; 40:1199-1202.
2. Centers for Disease Control and Prevention. Treating Opportunistic Infections Among HIV-Infected Adults and Adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Disease Society of America. Morbity and Mortality Weekly Report 2004; 53[RR 15], 34-35.
3. Holanda EM, Mesquita JRL, Pinheiro MZ, Ângelo MRF, Silva TMJ. Importância do creme leucocitário no diagnóstico da Histoplasmose Disseminada em pacientes com AIDS no Hospital São José (HSJ) - Ceará. Rev Soc Bras Med Trop 1998; 31(supl 1): 37-37.
4. Daher EF, Barros FAS, Silva Jr GB, Takeda CFV, Mota RMS, Ferreira MT, et al. Risk Factors for Death in acquired immunodeficiency syndrome-associated Disseminated Histoplasmosis. Amer J Trop Med Hyg 2006; 74:600-603.
5. Borges AS, Ferreira MS, Silvestre MT, Nishioka SA, Rocha A. Histoplasmosis in immunodepressed patients: study of 18 cases seen in Uberlandia, MG. Rev Soc Bras Med Trop 1997; 30:119-124.
6. Pietrobon D, Negro-Marquínez L, Kilstein J, Galíndez J, Greca A, Battagliotti C. Disseminated histoplasmosis and AIDS in an Argentine hospital: clinical manifestations, diagnosis and treatment. Enferm Infec Microbiol Clín 2004; 22:156-159.
7. McKinsey DS, Spiegel RA, Hutwagner L, Stanford J, Driks MR, Brewer J, et al. Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, and pathophysiology. Clin Infect Dis 1997; 24:1195-1203.
8. Hajjeh RA, Pappas PG, Henderson H, Lancaster D, Bamberger DM, Skahan KJ, et al. Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons. Clin Infect Dis, 2001, 32:1215-1220.
9. Daher EF, Silva Jr GB, Barros FA, Takeda CF, Mota RM, Ferreira MT, et al. Clinical and Laboratory features of disseminated histoplasmosis in HIV patients from Brazil. Trop Med Iternat Health 2007; 12:1108-1115.
10. Huber F, Nacher M, Aznar C, Pierre-Demar M, Elguedj M, Vaz T, et al. AIDS-related Histoplasma capsulatum var. Capsulatum infection: 25 years experience of French Guiana. AIDS 2008; 22:1047-1053.
11. McKinsey DS, Wheat LJ, Cloud GA, Pierce M, Black JR, Bamberger DM, et al, National Institute of Allergy and Infectious Diseases Mycoses Study Group. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. Clin Infect Dis 1999, 28:1049-1056.
12. Wheat LJ, Kauffman CA. Histoplasmosis. Infect Dis Clin of North America, 2003, 17:1-19.
13. Couppié P, Sobesky M, Aznar C, Bichat S, Clyti E, Bissuel F, et al. Histoplasmosis and acquired immunodeficiency syndrome: a study of prognostic factors. Clin Infect Dis 2004; 38:134-138.
14. Wheat LJ, Chetchotisakd P, Williams B, Connolly P, Shutt K, Hajjeh R. Factors associated with severe manifestations of histoplasmosis in AIDS. Clin Infect Dis 2000; 30: 877-881.
15. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mort Week Rep 1993; 41 [RR 17], 1-19.
16. Wheat LJ, Freifeld AG, Kleiman MB, Baddley JW, McKinsey DS, Loyd JE, et al. Clinical practice guidelines for the management of patiens with histoplasmosis: 2007 update by the infectious diseases society of america. Clin Infect Dis 2007; 45:807-825.